Empirical Wealth Management’s Globus Medical GMED Stock Holding History

Empirical Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$695K	Buy	8,802 +5,429	+161%	+$461K	0.01%	529
2026 Q1	$291K	Buy	+3,373	New	+$303K	0.01%	802

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Empirical Wealth Management's GMED Position: Q2 2026 in Review

Empirical Wealth Management increased its Globus Medical (GMED) stake by 161% in Q2 2026, buying an estimated $461K and bringing the position to 8,802 shares worth $695K. The position accounts for 0.01% of the portfolio, ranked #529.

Empirical Wealth Management first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Empirical Wealth Management held 8,802 shares of Globus Medical worth $695K as of Q2 2026.
Empirical Wealth Management bought 5,429 Globus Medical shares in Q2 2026, an estimated $461K.
Globus Medical made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #529 holding.
Empirical Wealth Management first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.